CBUS

1.2101.63%
GF

Gregory F. Gocal

Co-Founder, Chief Scientific Officer & Executive VP

Dr. Gregory F. Gocal, Ph.D., also known as Greg, co-founded of Cibus Global, Ltd. since 2016 (also known as, Calyxt, Inc.) and had been its Chief Scientific Officer and Executive Vice President since 2016. He is Co-Founder at Cibus, Inc. and serves as its Chief Scientific Officer & Executive Vice President since 2016. Dr. Gocal has been the Co-Founder, Chief Scientific Officer and Executive Vice President of Cibus Ltd. since March 17, 2016 and served as its Senior Vice President of Research & Development from July 2014 to March 17, 2016 and previously served as its Vice President of Research. With an extensive background in molecular biology, Dr. Gocal is central in developing the RTDS technology in plant and microbial systems. Dr. Gocal is overseeing scientific activities to deliver on many of RTDS's new applications. Dr. Gobal was primarily focused on developing the molecular aspects of the technology, including target characterization, mutation discovery, molecular screening and assay development. Prior to joining Cibus, Dr. Gocal headed the molecular biology group of the Plant and Industrial Products Division at ValiGen. Dr. Gocal worked at CSIRO Plant Industry in Canberra, Australia. Dr. Gocal has authored numerous peer-reviewed publications. Dr. Gocal is a Co-inventor of several patent applications. Dr. Gocal received his PhD in Plant Molecular Biology from the Australian National University while studying floral initiation of a grass Lolium temulentum. Dr. Gocal continued to study the molecular biology of floral initiation/development as a Postdoctoral Scientist at the Salk Institute for Biological Studies in La Jolla, Calif. He earned a BSc in Biochemistry/Botany and an MSc in Plant Physiology from the University of Calgary.

公司職務